Reports
Reports
Sale
The global organ preservation market was valued at USD 281.7 million in 2023, driven by the increasing number of organ transplant procedures. The market is expected to grow at a CAGR of 6.62% during the forecast period of 2024-2032, with the values likely to reach USD 500.2 million by 2032.
Organ transplantation is considered the best therapeutic alternative in case of terminal organ failure. There is a steady rise in the number of candidates for transplantation due to the increasing incidence of chronic diseases and the rapidly growing aging population. Since organ preservation devices and solutions are needed to maintain the viability of the organs intended to be transplanted, the market for organ preservation is expected to significantly grow in the coming years. Moreover, the rising advancements in organ preservation techniques that help extend preservation times while maintaining organ quality are likely to augment the market demand. Increased public awareness about the importance and impact of organ donation is anticipated to bolster the market growth.
Increasing Organ Donation and Transplants Set to Drive Market Growth
According to the preliminary data released by the Organ Procurement and Transplantation Network (OPTN) , 16,335 individuals in the United States donated one or more organs upon death in 2023, which represented a 9.6% increase in donation compared to 2022. Further, it was reported that over 46,000 organ transplants were performed in 2023, with more than 10,000 liver transplants estimated to be performed for the first time. These annual record-setting trends in organ donation and transplantation in the United States are projected to contribute significantly to the market demand for effective organ preservation solutions and techniques.
Substantial Investments to Meet Rising Organ Preservation Market Demand
In July 2023, Oxford-based medical equipment manufacturer OrganOx secured a EUR 29 million growth investment in a financing round led by healthcare-focused investment company Lauxera Capital Partners. The investment is aimed at boosting the development and commercialization of its organ preservation and transplantation devices. The company’s device metra is FDA-approved to preserve the liver by recreating an environment for the recovered organ that simulates the human body. OrganOX intends to leverage this investment to expand its market presence, establish new manufacturing centers, and conduct post-market clinical evaluations. Such substantial investments in the companies engaged in organ preservation are likely to propel the market growth.
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
Advancements in Organ Preservation Techniques to Affect the Market Landscape
The rising advancement in preservation techniques such as hypothermic machine perfusion (HMP) and normothermic machine perfusion (NMP) is a significant market trend that has optimized the preservation process of donor organs. Such technologies ensure that the viability of organs remains for longer periods, thereby contributing to market growth.
Increased Government and Non-Profit Initiatives Likely to Elevate the Organ Preservation Market Value
One of the major market trends is the increased initiatives by governments and non-profit organizations to promote organ donation among the public through awareness campaigns, educational programs, and policy initiatives. Such efforts often lead to a higher number of individuals willing to donate their organs, which ultimately elevates the market value.
Efforts to Simplify the Donation Process are Expected to Impact Market Growth
Increased efforts to simplify the organ donation process is a major trend that is expected to drive market growth. This trend includes initiatives that make the process of registering as an organ donor easy and accessible such as by implementing online registration systems. Such streamlined registration processes are anticipated to encourage more organ donations which will also increase the demand for organ preservation solutions.
Improvements in Donation and Transplantation Infrastructure Poised to Boost Organ Preservation Market Size
The market is witnessing improvements in the infrastructure for organ donation and transplantation. This facilitates better coordination between organ donation organizations and transplant centers. Upgraded transplant centers have the ability to handle complex transplant procedures and have the required technology to provide specialized care to both donors and recipients. Such developments are likely to improve the success rates of organ transplants and boost the market size.
Market Breakup by Techniques
Market Breakup by Organ Type
Market Breakup by Product Type
Market Breakup by End User
Market Breakup by Region
Market Segmentation Based on Organ Poised to Hold a Substantial Market Share
The market breakup by organ includes the kidney, liver, lung, heart, and pancreas among others. Out of these, kidney transplants hold a significant market share, which can be attributed to the increasing incidence of kidney-related diseases. With the rising prevalence of obesity, alcohol consumption and unhealthy dietary habits, the probability of patients requiring kidney transplants has increased in recent years.
Based on the region, the market report offers insights into North America, Europe, Asia Pacific, and Latin America, and Middle East and Africa. North America is a major player in the market owing to a high prevalence of chronic diseases that require organ transplants. The presence of an advanced healthcare infrastructure and a strong focus on research and development also fuels the market growth. The rising number of organ donation rates in regions like the United States stimulated by various government and non-profit initiatives is expected to elevate the market value in the forecast period.
The key features of the market report comprise the grants analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:
Bridge to Life Limited
United States-based Bridge to Life Limited is a global supplier of organ preservation solutions and perfusion technologies. Some of its key products include VitaSmart™ Machine Perfusion System and Belzer UW® Cold Storage Solution.
Avionord SRL
Based in Milan, Italy, Avionord is a major distributor of medical technology products including perfusion machines. It is a leading player in the emergency air transport of surgeons who are involved in the collection of organs that are marked for transplantation and also of organs that travel without medical personnel.
Carnamedica S.P.
Carnamedica is a prominent player in the market and provides various medical devices and solutions that help facilitate organ preservation and transplantation. Solution LungProtect® is one of its popular formulations for the preservation of lungs.
Dr. Franz Köhler Chemie GmbH
Dr. Franz Köhler Chemie GmbH, headquartered in Bensheim, Germany, is one of the leading players in the market. Its product CUSTODIOL® is widely used as a preservation solution for multiple organ types.
Other key players in the market include Shanghai Genext Medical Technology Co., Ltd., Transplant Biomedicals S.L., Global Transplant Solutions Inc., Essential Pharmaceuticals Ltd., Institut Georges Lopez, OrganOx Limited, and Organ Recovery Systems Inc.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Techniques |
|
Breakup by Organ Type |
|
Breakup by Product Type |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Organ Preservation Market Overview
3.1 Global Organ Preservation Market Historical Value (2017-2023)
3.2 Global Organ Preservation Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Organ Preservation Market Landscape*
5.1 Global Organ Preservation Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Organ Preservation Market: Product Landscape
5.2.1 Analysis by Techniques
5.2.2 Analysis by Organ Type
5.2.3 Analysis by Product Type
6 Global Organ Preservation Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Organ Preservation Market Segmentation (2017-2032)
7.1 Global Organ Preservation Market (2017-2032) by Techniques
7.1.1 Market Overview
7.1.2 Static Cold Storage
7.1.3 Hypothermic Machine Perfusion
7.1.4 Normothermic Machine Perfusion
7.2 Global Organ Preservation Market (2017-2032) by Organ Type
7.2.1 Market Overview
7.2.2 Kidney
7.2.3 Liver
7.2.4 Lung
7.2.5 Heart
7.2.6 Pancreas
7.2.7 Others
7.3 Global Organ Preservation Market (2017-2032) by Product Type
7.3.1 Market Overview
7.3.2 Preservation Solutions
7.3.3 Transport Systems
7.3.4 Others
7.4 Global Organ Preservation Market (2017-2032) by End User
7.4.1 Market Overview
7.4.2 Hospitals
7.4.3 Organ Transplant Centers
7.4.4 Others
7.5 Global Organ Preservation Market (2017-2032) by Region
7.5.1 Market Overview
7.5.2 North America
7.5.3 Europe
7.5.4 Asia Pacific
7.5.5 Latin America
7.5.6 Middle East and Africa
8 North America Organ Preservation Market (2017-2032)
8.1 North America Organ Preservation Market (2017-2032) By Techniques
8.1.1 Market Overview
8.1.2 Static Cold Storage
8.1.3 Hypothermic Machine Perfusion
8.1.4 Normothermic Machine Perfusion
8.2 North America Organ Preservation Market (2017-2032) by Organ Type
8.2.1 Market Overview
8.2.2 Kidney
8.2.3 Liver
8.2.4 Lung
8.2.5 Heart
8.2.6 Pancreas
8.2.7 Others
8.3 North America Organ Preservation Market (2017-2032) by Product Type
8.3.1 Market Overview
8.3.2 Preservation Solutions
8.3.3 Transport Systems
8.3.4 Others
8.4 North America Organ Preservation Market (2017-2032) by End User
8.4.1 Market Overview
8.4.2 Hospitals
8.4.3 Organ Transplant Centers
8.4.4 Others
8.5 North America Organ Preservation Market (2017-2032) by Country
8.5.1 United States of America
8.5.2 Canada
9 Europe Organ Preservation Market (2017-2032)
9.1 Europe Organ Preservation Market (2017-2032) By Techniques
9.1.1 Market Overview
9.1.2 Static Cold Storage
9.1.3 Hypothermic Machine Perfusion
9.1.4 Normothermic Machine Perfusion
9.2 Europe Organ Preservation Market (2017-2032) by Organ Type
9.2.1 Market Overview
9.2.2 Kidney
9.2.3 Liver
9.2.4 Lung
9.2.5 Heart
9.2.6 Pancreas
9.2.7 Others
9.3 Europe Organ Preservation Market (2017-2032) by Product Type
9.3.1 Market Overview
9.3.2 Preservation Solutions
9.3.3 Transport Systems
9.3.4 Others
9.4 Europe Organ Preservation Market (2017-2032) by End User
9.4.1 Market Overview
9.4.2 Hospitals
9.4.3 Organ Transplant Centers
9.4.4 Others
9.5 Europe Preservation Market (2017-2032) by Country
9.5.1 United Kingdom
9.5.2 Germany
9.5.3 France
9.5.4 Italy
9.5.5 Others
10 Asia Pacific Organ Preservation Market (2017-2032)
10.1 Asia Pacific Organ Preservation Market (2017-2032) By Techniques
10.1.1 Market Overview
10.1.2 Static Cold Storage
10.1.3 Hypothermic Machine Perfusion
10.1.4 Normothermic Machine Perfusion
10.2 Asia Pacific Organ Preservation Market (2017-2032) by Organ Type
10.2.1 Market Overview
10.2.2 Kidney
10.2.3 Liver
10.2.4 Lung
10.2.5 Heart
10.2.6 Pancreas
10.2.7 Others
10.3 Asia Pacific Organ Preservation Market (2017-2032) by Product Type
10.3.1 Market Overview
10.3.2 Preservation Solutions
10.3.3 Transport Systems
10.3.4 Others
10.4 Asia Pacific Organ Preservation Market (2017-2032) by End User
10.4.1 Market Overview
10.4.2 Hospitals
10.4.3 Organ Transplant Centers
10.4.4 Others
10.5 Asia Pacific Organ Preservation Market (2017-2032) by Country
10.5.1 China
10.5.2 Japan
10.5.3 India
10.5.4 ASEAN
10.5.5 Australia
10.5.6 Others
11 Latin America Organ Preservation Market (2017-2032)
11.1 Latin America Organ Preservation Market (2017-2032) By Techniques
11.1.1 Market Overview
11.1.2 Static Cold Storage
11.1.3 Hypothermic Machine Perfusion
11.1.4 Normothermic Machine Perfusion
11.2 Latin America Organ Preservation Market (2017-2032) by Organ Type
11.2.1 Market Overview
11.2.2 Kidney
11.2.3 Liver
11.2.4 Lung
11.2.5 Heart
11.2.6 Pancreas
11.2.7 Others
11.3 Latin America Organ Preservation Market (2017-2032) by Product Type
11.3.1 Market Overview
11.3.2 Preservation Solutions
11.3.3 Transport Systems
11.3.4 Others
11.4 Latin America Organ Preservation Market (2017-2032) by End User
11.4.1 Market Overview
11.4.2 Hospitals
11.4.3 Organ Transplant Centers
11.4.4 Others
11.5 Latin America Organ Preservation Market (2017-2032) by Country
11.5.1 Brazil
11.5.2 Argentina
11.5.3 Mexico
12 Middle East and Africa Organ Preservation Market (2017-2032)
12.1 Middle East and Africa Organ Preservation Market (2017-2032) By Techniques
12.1.1 Market Overview
12.1.2 Static Cold Storage
12.1.3 Hypothermic Machine Perfusion
12.1.4 Normothermic Machine Perfusion
12.2 Middle East and Africa Organ Preservation Market (2017-2032) by Organ Type
12.2.1 Market Overview
12.2.2 Kidney
12.2.3 Liver
12.2.4 Lung
12.2.5 Heart
12.2.6 Pancreas
12.2.7 Others
12.3 Middle East and Africa Organ Preservation Market (2017-2032) by Product Type
12.3.1 Market Overview
12.3.2 Preservation Solutions
12.3.3 Transport Systems
12.3.4 Others
12.4 Middle East and Africa Organ Preservation Market (2017-2032) by End User
12.4.1 Market Overview
12.4.2 Hospitals
12.4.3 Organ Transplant Centers
12.4.4 Others
12.5 Middle East and Africa Organ Preservation Market (2017-2032) by Country
12.5.1 Saudi Arabia
12.5.2 United Arab Emirates
12.5.3 Nigeria
12.5.4 South Africa
12.5.5 Others
13 Regulatory Framework
14 Grant Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Product
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Strategic Initiatives
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Market Share Analysis, By Region (Top 5 Companies)
17.1.1 Market Share Analysis: Global
17.1.2 Market Share Analysis: North America
17.1.3 Market Share Analysis: Europe
17.1.4 Market Share Analysis: Asia Pacific
17.1.5 Market Share Analysis: Others
17.2 Bridge to Life Limited
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Company News and Developments
17.2.5 Certifications
17.3 Avionord SRL
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Company News and Developments
17.3.5 Certifications
17.4 Carnamedica S.P.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Company News and Developments
17.4.5 Certifications
17.5 Dr. Franz Köhler Chemie GmbH
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Company News and Developments
17.5.5 Certifications
17.6 Shanghai Genext Medical Technology Co., Ltd.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Company News and Developments
17.6.5 Certifications
17.7 Transplant Biomedicals S.L.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Company News and Developments
17.7.5 Certifications
17.8 Global Transplant Solutions Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Company News and Developments
17.8.5 Certifications
17.9 Essential Pharmaceuticals Ltd
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Company News and Developments
17.9.5 Certifications
17.10 OrganOx Limited
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Company News and Developments
17.10.5 Certifications
17.11 Institut Georges Lopez, SAS
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Company News and Developments
17.11.5 Certifications
17.12 Organ Recovery Systems Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Company News and Developments
17.12.5 Certifications
18 Global Organ Preservation Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.